Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Charalambos Andreadis, Akshay Sudhindra et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 8
A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acute Myeloid LeukemiaGabriel N. Mannis, Thomas G. Martin, Charalambos Andreadis et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3
A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin LymphomaSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Blood|2019Cited by 0